LENSAR, Inc. Common Stock LNSR
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $10.00 (+15.2% upside)
Key Stats
- Today's Range
- $8.42 – $8.70
- 50-Day Range
- $4.95 – $8.74
- 52-Week Range
- $4.95 – $13.43
- Volume
- 167K shs
- Average Volume
- 141K shs
- Market Cap
- $103.69 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 6.96
- Price / Sales
- 1.72
Short Interest
- Short Interest
- 5.49%
- Days to Cover
- 3.23
Financials (TTM)
- Revenue
- $60.26 million
- Net Income
- $34.70 million
- Net Margin
- 57.57%
- Return on Equity
- 232.78%
- Debt-to-Equity
- —
About LENSAR, Inc. Common Stock
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
Related Stocks
Compare head-to-head: LNSR vs SYK·LNSR vs BSX·LNSR vs RMD·LNSR vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.